{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "public health",
      "statistical model"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33713504",
  "DateCompleted": {
    "Year": "2021",
    "Month": "10",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "07",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e2224",
      "10.1002/rmv.2224"
    ],
    "Journal": {
      "ISSN": "1099-1654",
      "JournalIssue": {
        "Volume": "31",
        "Issue": "5",
        "PubDate": {
          "Year": "2021",
          "Month": "Sep"
        }
      },
      "Title": "Reviews in medical virology",
      "ISOAbbreviation": "Rev Med Virol"
    },
    "ArticleTitle": "Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France.",
    "Pagination": {
      "StartPage": "1",
      "EndPage": "8",
      "MedlinePgn": "1-8"
    },
    "Abstract": {
      "AbstractText": [
        "The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting disease COVID-19 has killed over 2 million people as of 22 January 2021. We have used a modified susceptible, infected, recovered epidemiological model to predict how the spread of the virus in France will vary depending on the public health strategies adopted, including anti-COVID-19 vaccination. Our prediction model indicates that the French authorities' adoption of a gradual release from lockdown could lead in March 2021 to a virus prevalence similar to that before lockdown. However, a massive vaccination campaign initiated in January 2021 and the continuation of public health measures over several months could curb the spread of virus and thus relieve the load on hospitals."
      ],
      "CopyrightInformation": "\u00a9 2021 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3713-4913"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "UMR Inserm, U1043, UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Virology Laboratory, Centre Hospitalier Universitaire (CHU) de Toulouse, H\u00f4pital Purpan, Toulouse, France."
          }
        ],
        "LastName": "Dimeglio",
        "ForeName": "Chlo\u00e9",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Laboratory, Centre Hospitalier Universitaire (CHU) de Toulouse, H\u00f4pital Purpan, Toulouse, France."
          }
        ],
        "LastName": "Miedoug\u00e9",
        "ForeName": "Marcel",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Toulouse Mathematics Institute, Universit\u00e9 de Toulouse, Toulouse, France."
          }
        ],
        "LastName": "Loubes",
        "ForeName": "Jean-Michel",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Laboratory, Centre Hospitalier Universitaire (CHU) de Toulouse, H\u00f4pital Purpan, Toulouse, France."
          }
        ],
        "LastName": "Mansuy",
        "ForeName": "Jean-Michel",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "UMR Inserm, U1043, UMR CNRS, U5282, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Virology Laboratory, Centre Hospitalier Universitaire (CHU) de Toulouse, H\u00f4pital Purpan, Toulouse, France."
          }
        ],
        "LastName": "Izopet",
        "ForeName": "Jacques",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Rev Med Virol",
    "NlmUniqueID": "9112448",
    "ISSNLinking": "1052-9276"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Communicable Disease Control"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "France"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Policy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "legislation & jurisprudence"
      ],
      "DescriptorName": "Public Health"
    },
    {
      "QualifierName": [
        "genetics",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "The authors have no conflict of interest to declare."
}